Acute kidney injury (AKI) is a major health care condition with limited current treatment options. Within this context, stem cells may provide a clinical approach for AKI. Moreover, a synthetic compound previously developed, hyaluronan monoesters with butyric acid (HB), able to induce metanephric differentiation, formation of capillary-like structures, and secretion of angiogenic cytokines, was tested in vitro. Thereafter, we investigated the effects of human mesenchymal stem cells from fetal membranes (FMhMSCs), both treated and untreated with HB, after induction of ischemic AKI in a rat model. At reperfusion following 45-min clamping of renal pedicles, each rat was randomly assigned to one of four groups: CTR, PBS, MSC, and MSC-HB. Renal function at 1, 3, 5, and 7 days was assessed. Histological samples were analyzed by light and electron microscopy and renal injury was graded. Cytokine analysis on serum samples was performed. FMhMSCs induced an accelerated renal functional recovery, demonstrated by biochemical parameters and confirmed by histology showing that histopathological alterations associated with ischemic injury were less severe in cell-treated kidneys. HB-treated rats showed a minor degree of inflammation, both at cytokine and TEM analyses. Better functional and morphological recovery were not associated to stem cells' regenerative processes, but possibly suggest paracrine effects on microenvironment that induce retrieval of renal damaged tissues. These results suggest that FMhMSCs could be useful in the treatment of AKI and the utilization of synthetic compounds could enhance the recovery induction ability of cells.
INTRODUCTION
and its incidence is growing over time. The incidence of AKI is variable relative to the population examined, up to 288 cases per 100,000 population and with an 11% Acute kidney injury (AKI) represents an increasingly frequent clinical condition in the field of Nephrology yearly increase (43). Moreover, AKI is a prognostic factor statistically related to mortality, hospitalization dura-and Intensive Care Units. Although treatment with novel drugs and advanced life support techniques have im-tion, and quality of life. In particular, in-hospital mortality is very high, especially in patients who need renal proved survival of patients with severe organ impairment (often characterized also by a multiorgan failure), replacement therapy, exceeding 50% (20,27). Research is very active in defining standards and support technol-AKI remains in any case a major public health burden ogies in order to prevent, diagnose, and treat AKI. A under gravity for 5 min. Each supernatant was transferred to a fresh tube, neutralized with fetal bovine se-revolutionary strategy of intervention may be represented by the application of regenerative medicine. rum (FBS), and then spun at 1500 rpm for 10 min. Each pellet was resuspended in 5 ml of DMEM containing In a probable future, stem cells may restore damaged organs in their complexity, but now they allow repairing 20% FBS, 10 U/ml penicillin, and 100 µg/ml streptomycin. Human mesenchymal stem cells from fetal mem-a variety of injuries, mainly acting as "pharmacological" agents.
branes (FMhMSCs) were seeded into 25-cm 2 flasks and grown at 37°C in 5% CO 2 . Nonadherent cells were re-There are many articles showing how stem cells may interact with adult tissues. In particular, mesenchymal moved after 1 week and medium (with 10% FBS) was changed subsequently every 4 days. stem cells (MSCs) are well characterized, easily available, and have been extensively studied both in vitro and Flow Cytometry Analysis. The fibroblast-like cells in vivo (4, 6, 9, 12, 13, (31) (32) (33) (34) 48, 49) . It has been demonobtained from fetal membrane cultures were harvested strated that MSCs are able to promote tissue repair in by treatment with 0.08% trypsin-EDTA and incubated many experimental settings. Here we employed human with 1 µg/10 6 cells antibodies conjugated with different MSCs to treat functional ischemia/reperfusion (I/R) influorescent probes for 40 min at 4°C in the dark. The jury in a wild-type rat model, in order to determine the antibodies used were: CD105 (Chemicon International, ability of MSCs to repair a nonstructural damage. Fur-Millipore, Billerica, MA), CD73, CD90, CD166, CD14, thermore, on the basis of encouraging experiences on CD34, CD44, and CD45 (Becton Dickinson, Franklin heart models (41,42), we employed MSCs treated with Lakes, NJ). After washing with PBS, cells were ananovel differentiating agents, such as monoesters of hyalyzed on a flow cytometer (FACSAria, Becton Dickinluronan with butyric acid (HB), in order to verify son) by collecting 10,000 events and the data analyzed whether MSC preconditioning could led to further enusing the FACSDiva Software (Becton Dickinson). hancements in I/R functional recovery. Hyaluronic acid Cytofluorimetric analysis of FMhMSCs confirmed a represents an efficient targeting system, because its remesenchymal antigenic profile (CD29 + , CD166 + , CD73 + , ceptor CD44 is expressed on a variety of cells and li-CD90 + , CD105 + , CD44 + , CD34 − , CD45 − , CD14 − ) as gand-receptor interaction leads to complex internalizashown in Table 1 , and the culture with specific media tion of transported molecules (18) , such as butyric acid, triggered the differentiation in osteocytes, adipocytes, a histone deacetylase inhibitor, which activates expresand chondrocytes, demonstrating the mesenchymal nasion of several genes, including those responsible for ture of the isolated population. In particular, the presgrowth control and cell differentiation (25) .
ence of the receptor of hyaluronic acid CD44 in more The aim of the study was to observe the effects of than 98% of cells strengthens the rationale for the use administration of human MSCs on recovery of renal of these esters. function following I/R damage in a rat model, confirm-Adipogenic Differentiation. To induce adipocyte difing our observations by histology and electron microsferentiation, cells were cultured using Mesenchymal copy. Additionally, an objective to accomplish was to Stem Cell Adipogenesis Kit (Chemicon International) detect and characterize possible positive effects induced according to the manufacturer's instructions. The by pretreatment of stem cells with novel differentiating growth medium was replaced every 2-3 days. After 2-3 agents. for 5 min; larger pieces of tissue were allowed to settle replaced every 2 days for 3-4 weeks. Pellets were formalin-fixed, embedded in paraffin, examined morphologically, and immunostained for type II collagen SYBR Green I, Roche Diagnostics). Primer sequences (Chemicon International), using Vectastain elite ABC used for real-time PCR are reported in Table 2 . kit (Vector Laboratories, Burlingame, CA) ( Fig. 1c ).
MATERIALS AND METHODS
Amplification included initial denaturation at 95°C for 10 min, 45 cycles of denaturation at 95°C for 10 s, Gene Expression. Cells were treated with HB or HBR (hyaluronan mixed esters of butyric and retinoic annealing at 55-65°C for 6-10 s, and extension at 72°C for 10 s performed at a temperature transition rate of acid) at the concentrations of 1, 1.5, 2, and 3 g/L for 7 days.
20°C/s. Fluorescence was measured at the end of each extension step. Specificity of the product was deter-Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA), following the manufacturer's mined by a melting curve analysis. After treatment with the esters, we analyzed the tran-instructions. For RT-PCR, cDNA was synthesized in a 21-µl reaction volume with 2 µg of total RNA and scription levels of genes expressed at the first stages of nephrogenic differentiation, at the level of metanephric SuperScript II RT (Invitrogen). In order to assess mRNA expression of genes specific for the metanephric mesen-mesenchyme. The results revealed that the use of HBR did not increase expression of the considered genes after chyme, 20 ng cDNA was used for real-time RT-PCR performed with a Lightcycler system (Roche Diagnos-7 days of treatment (data not shown). This result was partially expected, because precedent experiments had tics, Basel, Switzerland) and with the SYBR Green fast start kit (Lightcycler FastStart DNA MasterPLUS shown a selected action of this ester to induce cardio- genesis (41). We believed interesting in any case to test We assessed the secretion of angiogenic cytokines [follistatin (FST), hepatocyte growth factor (HGF), this molecule, because retinoic acid carries out an important role during renal development.
granulocyte-colony stimulating factor (G-CSF), interleukin-8 (IL-8), leptin, CD31, platelet-derived growth fac-Conversely the treatment with HB, with a peak at the concentration of 1 mg/ml, increased significantly the tor (PDGF-BB), vascular endothelial growth factor (VEGF), and angiopoietin] with Bio-Plex Pro TM angio-transcription levels of all the genes analyzed (t-test, p < 0.05) ( Fig. 2) . genesis assay. This is a magnetic bead-based multiplex assay allowing the measurement of angiogenesis bio-Endothelial Differentiation. Based on the fact that markers in cell culture supernatant. Samples were preendothelial repair would represent an important goal in pared according to the manufacturer's instructions. Data the prevention of chronic nephropathies, we tested the from the reaction were then acquired using the Luminex ability of FMhMSC to differentiate in capillary-like system. The concentrations values were normalized on structures. Analysis of capillary formation was pertotal protein amount. formed using Matrigel (ECM gel E1270, Sigma-Aldrich
Results are depicted in Figure 4 . FST is an inhibitor Co.), a semisolid medium. Fifty microliters of gel matrix of inflammation and a proangiogenic factor (19). It solution, diluted 1:2 with DMEM, was applied to each binds to activins, promoting tissue regeneration in the well on a 96-well plate and incubated for 1 h at 37°C; liver and kidney (24) . FST levels ( Fig. 4a ) were signifi-1 × 10 3 cells were then suspended in 50 µl of DMEM, cantly higher in the cells pretreated with HB, compared or HB 1 g/L in DMEM, plated onto the gel matrix and to control cells. This effect appeared at 48 h and mainincubated at 37°C. Capillary-like structures were obtained up to 14 days. The peak of release was observed served by optical microscopy after 2 h and at regular at 7 days, followed by a decrease, probably due to a intervals during the following 24 h. saturation effect or negative feedback. In any case, the Figure 3 shows the results of the Matrigel analysis. treatment with HB led to a significant increase of release We observed that FMhMSCs treated with HB (1 mg/ also at 14 days if compared to untreated cells. ml), were able to migrate and align themselves in Matri-HGF is one of the most important angiogenic and gel to form tubular-like structure already after 3-4 h antiapoptotic cytokines (26) . G-CSF is involved in the ( Fig. 3b ), differently than untreated cells that exhibited recruitment of granulocytes and stem cells from bone capillary-like features only after 8 h and at remarkably marrow (35) . Platelet endothelial cell adhesion molelower extent ( Fig. 3a) .
cule-1 [PECAM-1 (CD31)] is a marker of differentiating endothelial cells, involved in inflammatory response, in-Production of Angiogenic Cytokines. We tested the ability of FMhMSCs pretreated with HB to induce angi-ducing tissue repair and vessel reconstruction (46). HB resulted in an increased of HGF ( Fig. 4b ), G-CSF ( Fig 4c), and PECAM-1 ( Fig. 4d ) release, compared to the it is implicated in repair of damaged vessels and generation of new ones (10) . This cytokine ( Fig. 4e ) and VEGF control, with a zenith at 14 days.
HB did not affect the secretion of IL-8 ( Fig. 4f ), a ( Fig. 4g ) revealed a common pattern, with a rise in their release up to 14 days, but without any difference com-chemokine involved in inflammatory response and angiogenic activity in tumors.
pared to the control. Leptin is produced by adipose tissue and has an im-PDGF-BB is secreted by platelets, it stimulates the growth of preexisting vessels, and together with TGF-β portant role in angiogenesis process increasing the levels of VEGF (8) . Angiopoietin is a growth factor able to Bologna. Thirty-six male Sprague-Dawley rats (weighing 230-280 g) were used for this experiment. The ani-promote angiogenesis and the formation of new blood vessels from preexisting ones (36) . Both leptin ( Fig. 4h ) mals were anesthetized with xylazine-tiletamine/zolazepam (Zoletil, Virbac, Carros, France) and placed on and angiopoietin ( Fig. 4i ) were not initially expressed by control or treated cells, but they were secreted at 7 a deltaphase heating pad (2Biol, Besozzo, Italy). The abdominal cavity was accessed transperitoneally through days and 72 h, respectively. The release of leptin was higher in cells treated with HB compared to control, at a midline xyfopubic incision to gain access to both kidneys. All animals underwent an ischemia-reperfusion 7 days. We could not observe any difference in angiopoietin secretion.
damage by bilateral 45-min clamping of both renal pedicles. At reperfusion each animal was randomly assigned The potentiality for nephrogenic transdifferentiation of cultured FMhMSCs after treatment with HB was also to one of four therapy groups: CTR-control group; PBS-administration of 0.15 ml of PBS; MSC-admin-tested. We observed that treatment with 1 g/L of HB induced the highest expression of genes specific for istration of 1 × 10 6 FMhMSCs suspended in 0.15 ml of PBS; MSC-HB-administration of 0.15 ml suspension metanephric mesenchyme. Furthermore, cells showed the ability of forming capillary-like structures and en-of 1 × 10 6 FMhMSCs pretreated with esters of hyaluronic and butyric acids (1 g/L for 14 days). PBS and stem hanced secretion of the angiogenic cytokines considered, with elevated production of anti-inflammatory mole-cells were injected directly into the cortex of only the left kidney. Right kidneys served as intragroup controls. cules ( Fig. 4 ).
Intraparenchymal administration was performed with a Study Protocol 24-gauge syringe in 4-5 injections of 0.03-0.05 ml each at different locations along the lateral aspect of the Taken together, the preliminary results of the in vitro kidney. studies on HB-treated FMhMSCs suggest that the cells are able to express markers of nephrogenic differentia-Histology and Immunohistochemistry. After animals tion and to form capillary-like structures: we then tested sacrifice, both kidneys were recovered and cut along whether these cells could help tissue repair in a model median-longitudinal axis by a razor blade, fixed in 10% of ischemic renal acute damage in wild-type rats.
buffered formalin, and then embedded in paraffin; 4 µm-Study Design. Twenty-four animals were followed to thick-sections were used for histological and immuno-7 days of survival. The animals were monitored in metahistochemical analysis. Each section was stained with bolic cages to monitor urine output. At days 1, 3, 5, and hematoxylin and eosin and observed under a light mi-7 (i.e., at sacrifice) urine and blood samples were colcroscope (LM) to quantify the amount of renal damage lected and analyzed by standard laboratory methodolousing the histological score proposed by Karpinski et al. gies. Urinary sodium, creatinine, and urea were determined (15). and urine output was registered. Serum creatinine, urea,
Immunohistochemical study was performed with an and sodium were measured. Creatinine clearance and anti-human mitochondria antibody (Chemicon Internafractional excretion of sodium were calculated using stantional) and a non-biotin-amplified method (NovoLink TM dard formulas. Both kidneys of each animal underwent Polymer Detection System, Novocastra Laboratories histological evaluation with light microscopy to assess re-Ltd., Newcastle Upon Tyne, UK) to evaluate the pressidual renal damage. To quantify the amount of damage ence of the administered stem cells in the tissue. Briefly, we used an histological score proposed by Karpinski et tissue sections were deparaffinated with xylene, rehyal. (15) that takes glomerular, tubular, interstitial, and vasdrated through a series of graded ethanol, and rinsed in cular components into account. Immunohistochemistry distilled water. Antigens were unmasked with citrate assays were performed with an anti-human mitochondria buffer pH 6.0, at 120°C, 1 atm for 21 min; endogenous antibody (1:100, Chemicon International) to detect and peroxidase activity was neutralized using a Novocaslocalize the administered stem cells in the tissue. tra TM Peroxidase Block and washed with Tris-buffered An additional 12 animals were sacrificed at 24 h from saline (TBS) 1×. After that, the slides were incubated reperfusion, in order to study premature response to with Novocastra TM Protein Block for 5 min in a wet damage. In these animals, equally randomly divided into chamber to reduce the nonspecific binding of primary the four treatment arms, blood samples were harvested antibody and polymer reagent, and rinsed in TBS 1×. preischemia and at 1, 6, and 24 h postischemia. At sacri-
The samples were subsequently incubated with the fice kidneys were fractioned and prepared for histologimonoclonal antibodies (mAb) against anti-human mitocal and immunohistochemical analyses. chondria (1:100, Chemicon International) in PBS/1% bovine serum albumin overnight at 4°C. After removal Surgical Procedure. All animal experiments were approved by Bioethics Committee of the University of of unbound antibody, the slides were incubated for 30 min at RT with Novocastra TM Post Primary Block to en-ferences in the timing of functional recovery. The two groups of rats treated with cells (MSC and MSC-HB), hance penetration of the next polymer reagent, rinsed in TBS 1×, and incubated with NovoLink TM Polymer for in particular, presented both a less severe AKI and a rapid course. 30 min at RT. Further, the sections were exposed to the substrate/chromogen 3,3′-diaminobenzidine (DAB) pre-Results are summarized in Figure 5 . Cell-treated groups had significantly lower serum creatinine (Fig. 5a ) pared from Novocastra TM DAB Chromogen and Novo-Link TM DAB Substrate Buffer, rinsed in distilled water, and urea levels (Fig. 5b) compared to the control groups CTR and PBS (p < 0.05). Creatinine clearance (Fig. 5c ) and counterstained with Gill's hematoxylin. Subsequently, the samples were dehydrated, coverslipped, and on day 1 was markedly reduced in all groups, but at day 7 it returned to normal levels. MSC and MSC-HB viewed in a LM using the Image-Pro Plus program. Negative control was obtained by omitting the primary groups recovered renal function, as expressed by creatinine clearance, significantly faster than the controls mAb.
(p < 0.05). Electron Microscopy. Specimens from each kidney Fractional excretion of sodium (FE-Na) (Fig. 5d ) were isolated from the cortical zone and fixed in glutarpeaked to abnormal levels at day 1 in control groups, aldehyde 2.5% buffered in phosphate 0.1 M. After a while cell-treated rats maintained normal values, with postfixation in osmium tetroxide 1% in cacodylate differences characterized by a high statistical signifibuffer, the samples were dehydrated in graded ethanol cance (p < 0.001). Measurements of FE-Na resulted and embedded in araldite. Ultrathin sections were counwithin the normal levels in all groups. Serum sodium terstained in uranyl acetate and lead citrate before obserlevels dropped significantly on day 1 in controls, while vation with a Philips 410 transmission electron microretaining normal levels in the treated groups (p < 0.05). scope.
On successive determinations natremia levels did not Cytokine Secretion Analysis. Blood samples were andiffer among the groups. alyzed using Milliplex TM Map Rat Cytokine/Chemokine Urine osmolarity (Fig. 5e ) was reduced on day 1 in kit (Millipore) for the following cytokines: VEGF, granall rats and rose from day 1 to day 7 with no significant ulocyte-macrophage colony stimulating factor (GM-CSF), differences between the groups. A trend toward a faster interferon (IFN-γ), IL-1α, IL-1β, IL-6, IFN-inducible rise of osmolarity, however, could be observed in MSC protein-10 (IP-10), monocyte chemotactic protein-1 and MSC-HB groups compared to the control groups. (MCP-1), and macrophage inflammatory protein-1α
Urinary protein levels (Fig. 5f) were not significantly (MIP-1α). Twenty-five microliters of sample per well different among the groups. was used. Cytokine analysis was performed following the manufacturer's instructions. Data were normalized
Histology and Immunohistochemistry to preischemia values.
As shown in Figure 6 (left panel), we observed dif-Statistical Analysis. For in vitro study, statistical ferent grades of renal injury at 24 h post-I/R with prianalysis was performed by using a one-way analysis of marily tubular necrosis, epithelium loss, swelling, blebvariance (ANOVA) and assuming a value of p < 0.05 bing, and hyaline casts; tubular injury was usually as the limit of significance. For in vivo study, data are patchy; glomeruli were characterized by minor damages. expressed as means (95% CI). Statistical analyses were Kidney biopsies scored according to Karpinski et al. performed for each time point with ANOVA on rank (15) showed moderately injured right and left organs in with Tukey post hoc test to evaluate for differences bethe CTR group (mean right + left score 2.17 ± 0.68 and tween renal score. A value of p < 0.05 was assumed as mean left score 2.17 ± 0.72). Similar values were rethe limit of significance. The statistical analyses were corded for the PBS group with mean right + left score performed using SAS 9.1 software (SAS Institute Inc., of 1.89 ± 0.78 and mean left score of 2.00 ± 0.63, while Cary, NC).
MSC (mean right + left score 1.22 ± 0.67 and mean left score 1.50 ± 0.55) and MSC-HB (mean right + left score RESULTS
1.22 ± 0.67 and mean left score 1.17 ± 0.75) had signifi-Recovery From Renal Damage cantly lower scores when compared to CTR (p < 0.05). No significant differences were observed between right Parameters describing renal function show that the peak of maximum functional decrease was at 24 h from and left kidneys with a trend for lower injury scores in left (compared to right) kidneys of MSC-HB rats (p > induction of renal damage. This condition of AKI improved at 3 and 5 days and renal function returned to 0.05). Major reparative phenomena were observed mostly at 7 days post-I/R, with large hyperchromatic nu-normal levels at 7 days from induction of ischemia-reperfusion (I/R) damage. Even though this trend was present clei, basophilic staining of tubular epithelial cytoplasm, and flattening of the tubular epithelial cells. Overall, tu-in all four groups, there was evidence of significant dif- bular injury was minimal and a significantly decreased glomerular levels. At 24 h from I/R injury, moderate to severe alterations were detected mainly in the tubular renal score was recorded both in right and left kidneys (CTR: mean right + left score 1.67 ± 0.51, mean left compartment: in particular CTR specimens were characterized by the presence of cell remnants in the tubular score 1.67 ± 0.58; PBS: mean right + left score 1.75 ± 0.89, mean left score 1.75 ± 0.96; MSC: mean right + lumen and by several epithelial cells with degenerative alterations and loss of organelles. The glomerular com-left score 1.00 ± 0.53, mean left score 0.83 ± 0.41; MSC-HB: mean right + left score 0.75 ± 0.46, mean left partment was well preserved from the ischemic insult. MSC rat samples revealed moderate degenerative as-score 0.67 ± 0.51). Representative images of histological analysis at 7 days are showed in Figure 6 (right panel).
pects like those observed in the controls. The glomeruli were normal appearing. On the contrary, MSC-HB kid-Again, the MSC and MSC-HB groups had significantly lower scores when compared with controls (p < 0.05) neys evidenced normal tubular epithelial cells together with presence of some mitotic figures ( Fig. 9 ) that could and left kidneys of the MSC-HB group had a substantially normal histological appearance.
be considered as a regenerative index. This result confirms a more rapid recovery in MSC-HB rats, as showed In order to evaluate the presence of injected FMhMSCs within the kidneys, immunohistochemistry with human by histological sections. At 7 days, CTR specimens exhibited degenerative anti-mitochondria antibody was performed in right and left kidneys at 7 days postinjury. Immunostaining lo-changes of mitochondria characterized by dilation and loss of electrondense matrix, and cristae appeared frag-cated human cells within the glomeruli, as well as in periglomerular and peritubular positions (Fig. 7) . The mented. These alterations seem to be likely due to an osmotic balance dysregulation. No differences between distribution of positively stained cells was extremely patchy; no particular pattern of distribution could be ob-CTR and PBS groups were detectable. The glomerular compartment featured moderate to severe alterations of served: cortical and juxtaglomerular regions were irregularly stained both in left and right kidneys. Quantitative podocytes and mesangial cells, characterized by picnotic nuclei. On the contrary, cell-treated kidneys had a nor-contribution of cell administration in renal parenchyma was modest; thus, no cell counts were performed. mal appearing morphology at the ultrastructural level: tubular epithelial cells showed well-shaped and com-Transmission Electron Microscopy pletely recovered mitochondria and glomerular cells showed normal submicroscopic morphology and archi-The electron microscopy analysis, as represented in Figure 8 , showed alterations visible both at tubular and tecture. At 7 days, kidneys of rats in the CTR group, both thelial cells can be characterized by irregular surface with thin microvilli indicating activation of likely imma-left and right (Fig. 10a, b ) displayed normal appearing capillaries lined with thin endothelial cells and exhibit-ture cells and neoformation of vessels. Figure 11 shows relevant details revealed by TEM analysis. ing a smooth surface.
Left and right kidneys of MSC group animals ( Fig.  Cytokine Analysis  10c, d) were characterized by vascular structures with a perivascular inflammatory infiltrate, constituted by some Results of cytokine analysis in serum of rats are summarized in Figure 12 . Serum levels of IFN-γ (Fig. 12a ) lymphocytes and monocytes. We observed endothelial cells with dispersed nuclear chromatin and electron-were significantly lower 24 h after I/R in cell-treated rats, compared with controls. The secretion of IP-10 lucent cytoplasm with few organelles.
In the MSC-HB group, both kidneys (Fig. 10e, f, left  (Fig. 12b) at this time was significantly decreased in MSC group compared with CTR. At 24 h the levels of and right kidney, respectively) showed vascular structures with almost similar features as in the MSC-treated IL-1β ( Fig. 12 c) were significantly lower in the MSC-HB group and IL-1α levels (Fig. 12d ) were significantly rats, but without the inflammatory infiltrate. Clear endo- lower in MSC rats, compared to CTR. Serum levels of of sodium. Some of these parameters, which reflect the excretory function of the kidney, indicated a better con-IL-6 ( Fig. 12e ) 1 h after I/R injury were significantly lower in cell-treated groups compared with PBS and in dition in cell-treated rats. Serum creatinine levels (Fig.  5a ) 1 day after treatment were lower in the MSC and MSC-HB group compared with CTR. The secretion of this cytokine in the MSC group was maintained signifi-MSC-HB groups, compared to controls (maximum value 2 vs. 3 mg/dl). We also noticed that in cell-treated cantly lower compared with PBS after 6 h. There was no significant difference between the four groups in se-groups serum creatinine returned to normal levels already at day 3, whereas control rats showed full restora-rum levels of MIP-1 (Fig. 12f ). Levels of MCP-1 (Fig.  12g ) were significantly increased in MSC-HB group tion only at day 7. The same trend could be observed for both serum urea levels ( Fig. 5b) and creatinine clear-after 6 and 24 h compared to the PBS group, and after 1 and 6 h compared to the MSC group. Serum VEGF ance (Fig. 5c ). Even FE-Na (Fig. 5d ) was worst in untreated rats on day 1, but it had a rapid recovery after 3 levels (Fig. 12h ) at 1, 6, and 24 h were significantly higher in the MSC-HB group compared to CTR and days from I/R damage, whereas in cell-treated groups it remained stable at low levels. PBS, and at 6 and 24 h compared to MSC.
The clinical trend was confirmed by morphological DISCUSSION studies: as expected, the histopathological alterations associated with I/R injuries were moderate in intensity, The aim of our study was first to demonstrate that the administration of FMhMSCs in a rat model could patchy in distribution, and mainly affecting the tubular compartment; glomeruli were almost undamaged if ana-be beneficial and lead to a faster recovery of reversible ischemic AKI. Second, we evaluated if the pretreatment lyzed both at light and electron microscopy. Cell-treated kidneys showed a slightly better score, compared to con-of FMhMSCs with HB could further enhance the repair of kidney injury, given the property of HB to induce the trols. We noticed that the protective effect was acting early and it could be detected already at 24 h from dam-secretion of cytokines and the differentiation of cells into metanephric progenitors or capillary-like structures. age induction, as there are signs of cell proliferation in renal tubular cells. Figure 9 demonstrates the presence Renal function trend was ameliorating during the 7 days after induction of I/R injury in all groups of rats, of a mitosis that could be detected only in the MSC-HB group. It is important to highlight that the cell-treated both untreated and treated with FMhMSCs administration. Finally, at day 7, kidney function was completely kidneys had this significant lower extent of damage already at 24 h from induction of same degree of ische-restored in all groups; however, some differences emerged in relation to severity of renal injury and time mia: we can hypothesize an important role of cell administration both in preventing I/R damage and promoting of recovery.
Cell-treated rats showed a less severe AKI, as it could effective repair. Seven days after I/R injury, there was a prompt re-be evaluated 1 day after I/R injury by analyzing biochemical parameters, such as serum levels of creatinine covery of tubular damage in all the groups considered; however, cell-treated kidneys healed more efficiently, and urea, creatinine clearance, and fractional excretion particularly those injected with HB-treated FMhMSCs. In this group, light and electron microscopy revealed an almost complete structural recovery.
It has been demonstrated that MSCs from bone marrow can migrate to the site of kidney damage (11, 12) and contribute to injury recovery, especially in studies with models of sex-mismatched bone marrow or kidney transplantation (28, 29) . However, migration and homing of MSCs are not yet fully understood even though the production of G-CSF from renal mTAL cells (52) after an ischemic damage and CD44-hyaluronic acid interaction (11) seems to play a significant role.
The mechanisms through which exogenous MSCs promote tissue repair are even more complex and for many aspects controversial. Some authors indicated that MSCs may act by transdifferentiation or cell fusion to replace the lost cells (28, 29) , and this mechanism would works, we observed both functional improvement and a promptly from AKI. After all, the anti-inflammatory effect of stem cells is well known, because there are sev-better architectural tissue organization.
Cytokine serum assays suggest that in the present ex-eral papers showing the ability of stem cells to reduce both cellular and humoral immune responses (1, 14, 17 , perimental setting FMhMSCs may restore renal function through a paracrine mechanism most likely involving 22,23). In particular, the administration of immature cells expressing major histocompatibility complex I also resident mesenchymal and tubular epithelial cells (12). Indeed, in cell-treated groups we detected lower (MHCI) at low levels without second signal receptors, such as costimulatory molecules CD40, CD80 and levels of proinflammatory cytokines like IL-1α and IL-1β, IL-6, IFN-γ, and IP10 than in controls, whereas lev-CD86, induces immune responses that support tolerance by Treg and Th2 cell increase versus Th1 decrease, and els of factors that tend to lower the inflammatory response, like MCP-1 and VEGF, were increased (Fig. the production of IL-4 and IL-10 anti-inflammatory cytokines (29) . 12). A positive influence on the balance between proand anti-inflammatory stimuli was particularly evident
Confirming evidence of anti-inflammatory effects derives also from several experiments on combined trans-in MSC-HB-treated rats (Figs. 10, 12) , which recovered plantation of solid organs and stem cells (2, 44, 50, 51, 53) . and restoring cytoplasmatic structures, all features that ultrastructural studies documented. In this view, the use of MSCs in the treatment of AKI could represent an important instrument for inducing a
We were not able to detect large differences between the effects of normal FMhMSCs and HB-treated cells in modulation of the immune response and inflammation, fundamental for a faster recovery of renal function.
renal recovery, probably because the damage is prevalently functional with a mild organic injury, as con-In agreement with these observations and differently from what was observed in rats treated with FMhMSCs, firmed by histological features. This was proven by the evidence that damage was reversible per se, because un-electron microscopy did not evidence inflammatory responses in the group of rats treated with HB-FMhMSCs treated rats show full functional recovery just after 7 days from experimental procedures, with no need of ex- (Fig. 10) . A statistically significant increase in antiinflammatory molecules was one of the elements charac-tracorporeal renal substitution techniques. Presumably, in a setting of acute tubular necrosis (ATN), the effect terizing the preliminary in vitro steps of this study. These results indicate that administration of mesenchy-of differentiating molecules would be to induce tissue repair more rapidly. This eventuality needs to be verified mal stem cells, particularly when preconditioned with HB, could help to reduce levels of inflammation, which by different experimental models. Microscopy analyses showed a persisting and pre-is now recognized to be a very important factor in the pathophysiology of ischemic AKI (5) .
dominantly tubular damage in every group of rats, despite a full recovery of renal function. This result proves Although rats administered with HB-untreated and treated MSCs were characterized by a similar recovery how renal function restoration anticipates complete tissue repair and confirms that clinical parameters such as of renal function, we observed differences relative to their ability to secrete prosurvival and differentiating creatinine, urea, and FE-Na are not accurate enough in detecting mild and premature renal impairment, so that growth factors. Experimental in vitro procedures evidenced a controversial direct effect of HB-treated it is necessary to find more precise methods to determine the presence and amount of renal damage (16,40). FMhMSCs, characterized by an increment of several factors (e.g., follistatin and HGF), but not by an influ-In summary, we demonstrated that administered human FMhMSCs can improve renal function after I/R ence on VEGF secretion. In vivo studies, instead, showed that there is a 10 times increase in VEGF levels damage in a model of wild-type rat. This is confirmed by the analysis of clinical parameters and morphological in MSC-HB rats, compared either to controls and the MSC group. These results suggest that HB-treated aspects of injured kidneys. Our hypothesis is that the effect of FMhMSCs could be mediated by the secretion FMhMSC effect is due not only to their secretive ability, but also to an indirect stimulation of VEGF release, of factors, such as HGF and G-CSF, that stimulate recovery and it seems to influence the enhanced clinical probably from in situ cells. It is worth noting that VEGF appears to be one of the most important mediators of and functional trends. We also demonstrated that differentiating agents are able to induce an increased reactiv-renoprotection induced by FMhMSCs (39) . Cells treated with HB, moreover, secreted a certain number of angio-ity of FMhMSCs or a greater secretion of factors that stimulate differentiation. Pretreatment of cells with hya-genic factors (e.g., follistatin, HGF, G-CSF, PECAM-1, leptin), that could contribute to healing the injured kid-luronan esters could enhance FMhMSC properties in stimulating angiogenesis and vascular regeneration and ney (Fig. 3) . Accordingly, at the end of the experimental procedure, ultrastructural studies revealed not only a could potentially be useful in treatment of ATN.
There are still contrasting evidences on the contribu-complete recovery of tubular structures but also capillary neoformation, as depicted in Figures 10 and 11 .
tion of FMhMSCs to the restoration of renal damage. Some studies support the hypothesis for proliferation These features were evidenced only in animals that were administered with stem cells, both untreated and pre-and transdifferentiation of FMhMSCs at the site of damage (30, 45) . On the contrary, many works disagree and treated with HB.
Furthermore, these factors own important properties indicate that extrarenal cells have little or no effect at all. An important work by Humphreys and colleagues besides promoting angiogenesis. For example, follistatin is also known as an inhibitor of inflammation (19); HGF (12) reported that neither extrarenal cells nor medullary cells contribute to tissue repair by replacing lost cells in is one of the most important antiapoptotic cytokines and it is thought to inhibit fibrosis (47); PECAM-1 release kidney cortex. It is possible that restoration is mediated by cortex residential progenitor cells (21, 31) . is able to induce tissue repair and vessel reconstruction, beyond being a marker for endothelial differentiation Our hypothesis, however, is strongly supported by several works: tion indexes, and a minor extent of kidney damage (37) . 13 . In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur,
In conclusion, in our study FMhMSCs did not struc- 
